Unicycive Therapeutics, Inc. Share Price
Equities
UNCY
US90466Y1038
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | +6.19% | -3.74% | +18.70% |
Sales 2024 * | - | Sales 2025 * | 24.39M 1.95B | Capitalization | 35.8M 2.87B |
---|---|---|---|---|---|
Net income 2024 * | -25M -2B | Net income 2025 * | -28M -2.24B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.47 x |
P/E ratio 2024 * |
-1.86
x | P/E ratio 2025 * |
-3.27
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.6% |
1 day | +6.19% | ||
1 week | -3.74% | ||
Current month | -25.36% | ||
1 month | -29.45% | ||
3 months | +17.73% | ||
6 months | +69.05% | ||
Current year | +18.70% |
Managers | Title | Age | Since |
---|---|---|---|
Shalabh Gupta
CEO | Chief Executive Officer | 51 | 17/08/16 |
John Townsend
DFI | Director of Finance/CFO | 62 | 31/08/20 |
Pramod Gupta
COO | Chief Operating Officer | 63 | 31/08/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sandeep Laumas
BRD | Director/Board Member | 56 | 31/12/17 |
John Ryan
BRD | Director/Board Member | 80 | 31/12/17 |
Gaurav Aggarwal
BRD | Director/Board Member | 51 | 07/03/23 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.03 | +6.19% | 232,505 |
25/04/24 | 0.97 | -6.73% | 498,150 |
24/04/24 | 1.04 | -2.80% | 179,414 |
23/04/24 | 1.07 | -6.96% | 244,227 |
22/04/24 | 1.15 | +7.48% | 458,697 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.70% | 35.8M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- UNCY Stock